TORIPALIMAB for Bladder cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 33 adverse event reports in the FDA FAERS database where TORIPALIMAB was used for Bladder cancer.
Most Reported Side Effects for TORIPALIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 590 | 43.9% | 3 | 432 |
| Off label use | 276 | 20.5% | 29 | 137 |
| White blood cell count decreased | 144 | 10.7% | 0 | 74 |
| Anaemia | 67 | 5.0% | 17 | 8 |
| Hypothyroidism | 67 | 5.0% | 13 | 11 |
| Neutrophil count decreased | 67 | 5.0% | 0 | 25 |
| Nausea | 60 | 4.5% | 7 | 14 |
| Rash | 59 | 4.4% | 7 | 11 |
| Vomiting | 58 | 4.3% | 7 | 14 |
| Platelet count decreased | 53 | 3.9% | 3 | 30 |
| Diarrhoea | 50 | 3.7% | 6 | 16 |
| Neutropenia | 49 | 3.7% | 8 | 1 |
| Thrombocytopenia | 48 | 3.6% | 12 | 0 |
| Pyrexia | 46 | 3.4% | 2 | 13 |
| Decreased appetite | 43 | 3.2% | 9 | 9 |
Other Indications for TORIPALIMAB
Nasopharyngeal cancer (163)
Hepatocellular carcinoma (125)
Oesophageal carcinoma (72)
Lung neoplasm malignant (65)
Breast cancer (40)
Malignant melanoma (36)
Small cell lung cancer (36)
Hepatic cancer (34)
Renal cancer (34)
Oesophageal squamous cell carcinoma stage iv (29)
Other Drugs Used for Bladder cancer
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279)
PEMBROLIZUMAB (869)
GEMCITABINE (841)
CISPLATIN (780)
ENFORTUMAB VEDOTIN-EJFV (530)
NIVOLUMAB (512)
ATEZOLIZUMAB (487)
CARBOPLATIN (332)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326)
GEMCITABINE\GEMCITABINE (240)